A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods. Issue 9 (14th December 2022)

• Record Type: Journal Article
• Authors: Theofel, Nadine; Möller, Philipp; Vejmelka, Elke; Kramer, Claus; Tsokos, Michael; Scholtis, Stefan
• Is Part Of: Journal of analytical toxicology. Volume 46:Issue 9(2022)
• Page Start: e285
• Page End: e290
• Publication Date: 2022-12-14
• Subjects: Drugs -- Analysis -- Periodicals; Drugs -- Toxicity testing -- Periodicals; 615.907
• DOI: 10.1093/jat/bkac098
• Languages: English
• ISSNs: 0146-4760

Abstract

Abstract: Toxicologists are often confronted with the abuse of multiple drugs and are obliged to decide which compound may have been the cause of death. We report on a 21-year-old man (182 cm, 84 kg), who was found unconscious in his bed. Beside him, the police found several controlled substances, among them were dried opium poppy pods containing thebaine, codeine and morphine, a clear liquid with the designer benzodiazepines flualprazolam and clonazolam and a white powder with the imprint SGT-25, instead of SGT-78 (CUMYL-4CN-BINACA). These compounds were also found in the urine sample following a non-targeted gas chromatography–mass spectrometry and a targeted liquid chromatography–tandem mass spectrometry (LC–MS-MS) screening approach. Subsequently, these compounds were quantified in whole femoral blood and scalp hair. Based on the concentrations measured in femoral blood in particular, we assume that the deceased had taken a lethal dose of the designer benzodiazepines—flualprazolam (0.74 mg/L) and clonazolam (2.08 mg/L), an extremely high dose of the opiates—thebaine (0.81 mg/L), codeine (0.23 mg/L) and morphine (0.13 mg/L ) and a high dose of the synthetic cannabinoid—CUMYL-4CN-BINACA (0.01 mg/L). Besides postmortem concentrations, we also present electron impact and electrospray ionization mass spectra of compounds found in the vicinity of the decedent, namely the tryptamines—4-hydroxy- N -isopropyl- N -methyltryptamine (4-HO-MIPT), 4-hydroxy- N -ethyl- N -methyltryptamine (4-HO-MET) and 4-acetoxy- N, N -diethyltryptamine (4-ACO-DET), the amphetamines—3-fluoroethamphetamine (3-FEA) and 2-fluoromethamphetamine (2-FMA) and the arylcyclohexylamines— N -ethyldeschloroketamine (O-PCE), 3-methoxyphencyclidine (3-MeO-PCP) and 3-methoxyeticyclidine (3-MeO-PCE).